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A synthetic human gene of  CSF3 (CSF3syn.Ec3), coding for 
hG-CSF was succesfully subcloned into pET32a(+) expression 
vector and fused with thioredoxin (Trx) at its N-terminal as fusion 
partner. The obtained fusion gene of Trx-CSF3syn within the 
recombinant plasmid pET32a(+)_CSF3yn.Ec3 was verified by PCR, 
plasmid restriction, and DNA sequencing analysis. In order to 
investigate the fusion gene expression, we transformed 
Escherichia coli BL21(DE3) as the host with the recombinant 
plasmid. The gene was succesfully expressed within the cytosol as 
fusion protein of Trx·tag, His·tag, S·tag, EK-site, and hG-CSF 
moieties. By the auto induction method, 49% of the protein was 
found in the soluble fraction and the other 51% was found in the 
insoluble fraction. The soluble fraction was subsequently purified 
by IMAC method (Ni-NTA) and characterized. 
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INTRODUCTION  
Granulocyte colony stimulating factor 
(G-CSF) or colony stimulating factor 3 (CSF3) 
is a hematopoietic cytokines that activates and 
regulates the production of mature neutrophile, 
acts on cell survival and differentiation 
(Metcalf, 1987; Nagata, 1986). It has been 
studied to have indications in post 
chemotherapy neutropenia, bone marrow 
transplantation, severe chronic neutropenia, 
and in hematologic malignancies (Dale, 1998; 
Welte, 2012). 
Human G-CSF (hG-CSF) is 19.5kDa in 
molecular weight and O-glycosilated at Thr133 
(Souza, 1986 and Welte, 2012). Post 
translational modification is not an issue for 
hG-CSF because O-glycosilated bond does not 
bind with receptor, so both of the wild-type 
and non-glycosylated mutant recombinant hG-
CSF possess colony stimulating activities  
(Wingfield, 1988; Hill, 1993). However, the O-
glycosilated bond has an important role to 
avoid aggregation, thus, hG-CSF is frequently 
produced in E. coli as inclusion bodies 
(Yamamoto, 2002; Dasari, 2008). 
Thioredoxin (Trx) was used to improve 
the solubility of various eukaryotic proteins in 
E. coli (Lavielli, 1993; Yasukawa, 1995; Sandhev, 
1998). Therefore, we are fascinated to apply 
Trx as a fusion partner to obtain soluble hG-
CSF in E. coli BL21(DE3) using auto induction 
method. This method is more practical and less 
expensive than the conventional IPTG-induced 
method (Blommel, 2007, and Li, 2011). It is 
based on the principle of diauxic growth caused 
by two types of carbon source, i.e glucose and 
glycerol as the rapidly metabolized carbon 
sources and lactose as the slowly metabolized 
carbon source (Studier, 2005).  
The aim of this study is to develope a 
new approach to express soluble hG-CSF by 
fusing with Trx and investigate autoinduction 
as an alternative method for this fusion protein 
expression. Therefore, the larger or even 
commercial scale of hG-CSF will be more 
applicable, more effective and efficient. 
 
MATERIAL AND METHODS 
Subcloning of CSF3syn into expression 
vector pET32a(+) and its transformation 
into expression host Escherichia coli 
BL21(DE3)  
A synthetic gene coding hG-CSF             
was amplified by PCR of recombinant         
plasmid pTZ57R/T_CSF3syn.Ec using Applied 
Biosystem 2720 Thermal Cycler (Foster City, 
USA) (Wulandari, 2010). Restriction sites of 
BglII and stop codons were added by PCR 
amplification, this gene is subsequently named 
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CSF3syn.Ec3. The CSF3syn.Ec3 and pET32a(+) 
(Novagen, Darmstadt, Germany) were cut with 
restriction enzyme of BglII (Fermentas, Vilnius, 
Lithuania), then ligated with T4 DNA ligase kit 
(Fermentas, Vilnius, Lithuania). The ligation 
product was transformed into a cloning vector 
E. coli XL1-Blue (Fermentas, St. Leon Rot, 
Germany) by heat shock method (Sambrook, 
2001). The recombinant plasmid was verified 
by plasmid restriction and DNA sequencing 
analysis. In order to express the gene,                 
the recombinant plasmid was transformed          
into E. Coli BL21(DE3) (Novagen, Darmstadt, 
Germany) as by heat shock method (Sambrook, 
2001).  
 
Small scale overexpression of CSF3syn 
through autoinduced method 
Pre-inoculum was prepared from          
50µL glycerol stock of BL21(DE3)_pET32a(+) 
_CSF3syn.Ec3 in 1mL Luria Bertani medium 
(Sambrook, 2001) and incubated at 37°C, 
150rpm, 18h (Series 2G Incubator Shaker,  
New Brunswick Scientific, Edison, New           
Jersey, USA). The pre-inoculum was added into 
10mL ZYP-5052 autoinduction expression 
medium (Studier, 2005), then incubated at 
20°C, 170rpm, 24h (Heidolph Unimax 1010 
Incubator Orbital Shaker, Germany). The cells 
were resuspended in lysis buffer contains of 
100mM Tris-Cl pH 7.4; 3mM EDTA, and 
2mM PMSF (8mL/g wet cells pellet) and then 
lysed by freezing at -20°C and thawing in water 
bath at room temperature, app. 30min 
respectively, for ten cycles. Soluble protein was 
obtained by centrifugating the lysed cells at 
12,000 rpm for 15min, ±4°C (Heraeus 
Sepatech Biofuge 13, Germany). Chemical 
reagents and other components for medium 
were purchased from Merck, Sigma, Biobasic, 
and Caisson Labs.  
 
Purification and characterization hG-CSF 
The soluble crude protein was added to 
Ni-NTA agarose matrix (1 : 1) (Qiagen, Hilden, 
Germany), then incubated on a rotator for 18h 
at 4°C. The slurry was washed using 20mM and 
30mM imidazole (Biobasic, Markham, Canada), 
meanwhile the target fusion protein was 
recovered  by  elution  with 100mM imidazole in 
15 fractions.  
The imidazole solution was prepared in 0.16M 
Tris.Cl pH 7.4 buffer enriched with 4M NaCl. 
The first to the fourth elution fraction were 
collected and dialysed in 0.05M Tris.Cl pH 8.0 
buffer for 24h at 4°C with three times of buffer 
changing. The dialyzed protein was cut           
with enterokinase (EK) (Invitrogen, Carlsbad, 
USA), 1U enzyme for 100µg fusion protein, 
then was incubated at 4°C and 20°C for 16h, 
respectively. hG-CSF and 6His-Trx·tag were 
separated with IMAC as well. Both proteins 
were concentrated using NanoSep® centrifugal 
filter column (Pall Life Sciences, East Hills, 
New York, USA) from 300µL to 50µL. The 
proteins were characterized by western blot 
using mouse anti-His monoclonal primary 
antibody (GE Healthcare, Buckinghamshire, 
UK), goat anti-mouse IgG-AP secondary 
antibody (Santa Cruz Biotech, Santa Cruz, 
USA), and detected with Stabilized Substrate 
for Alkaline Phosphatase (Promega, Madison, 
USA). 
 
RESULTS AND DISCUSSION 
Subcloning of CSF3syn into expression 
vector pET32a(+) and its trans-
formation into E. coli BL21(DE3) 
The target gene was constructed to be 
expressed as fusion protein of hG-CSF with 
Trx·tag and 6×His·tag provided at the 
backbone of pET32a(+). The enterokinase 
(EK) site was added at N-terminal of hG-CSF 
which is functional towards separation of hG-
CSF and Trx·tag (Figure 1).  
Thirty three transformants of XL1-
Blue_pET32a(+)_csf3syn.Ec3 were gained, but 
there were only 14 transformants positively 
carry the insert of csf3syn.Ec3 (Figure 2.A); three 
transformants had proper orientation (Figure 
2.B), and two recombinant plasmid were 
succesfully cut with BglII (Figure 2.C).             
Those two transformants were analyzed by 
DNA sequencing and both of them had the 
correct DNA sequence (data not shown). To 
express the target gene, the recombinant 
plasmid was transfered from E.coli XL1-Blue  
to E.coli BL21(DE3), resulting 238 
transformants. Confirming by colony PCR,  
five of 20 randomly selected transformants 
were positively carrying the target gene. (Figure 
2.D). 
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Figure 2. DNA Electrophoresis  A. PCR product of pET32a(+)_CSF3syn.Ec3 with R- and F- insert 
gene primers. B. PCR product of pET32a(+)_CSF3syn.Ec3 with T7 promoter and R-insert gene 
primer C. pET32a(+)_CSF3syn.Ec3 cut with BglII, lane 1 and 3 shows CSF3syn.Ec3 as restriction 
product D. Colony PCR of BL21(DE3)_pET32a(+)_CSF3syn.Ec3 with R- and F- insert gene 
primers. M = 1 kb DNA Marker; NC = negative control; PC = positive control or recombinant 
plasmid pET32a(+)_CSF3syn.Ec3 
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Figure 3. Crude protein profile on 15% SDS-PAGE  
Lane 1) Protein Marker; Lane 2)Non transforman BL21(DE3) soluble protein, Lane 3) Non 
transforman BL21(DE3) insoluble protein, 4) Transforman without insert gene 
BL21(DE3)_pET32a(+) soluble protein, Lane 5) Transforman without insert gene 
BL21(DE3)_pET32a(+) insoluble protein, Lane 6 and 8) Transforman 
BL21(DE3)_pET32a(+)_CSF3syn.Ec3 soluble protein, 7 and 9) Transforman 





Figure 4. IMAC (Ni-NTA) purified protein profile on 15% SDS PAGE  
M) Protein Marker, C)Crude or unpurified protein, FT) Flow through, protein that not binds to the 
matrix, W20) Washing fraction with 20mM imidazole, W30) Washing fraction with 30mM 
imidazole, E1-E4) 1st to 4th elution fractions with 100mM imidazole 
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Small scale overexpression of CSF3syn 
through autoinduced method 
hG-CSF is prone to form inclusion 
bodies (IB) in E.coli because of its 
hydrophobicity and disulphide bonds 
(Dehaghani, 2010). This protein has five Cys 
residues that form two disulphide bonds 
between Cys37-Cys43 and Cys65-75, and 
another Cys18 a free Cys residue which is not 
involved in any disulphide bond formation 
(Wingfield, 1988). It is complicated to recover 
soluble protein from IBs related to initial 
recovery, solubilization, and renaturation steps,  
hence, fusion partners are commonly 
considered to obtain the soluble protein 
(Thatcher, 1990). 
 
Figure 5. Enterokinase cleaved fusion protein profile on 18% SDS PAGE 
Lane C.Rx) Control of reaction, contains of EK and EK buffer, Lane Crude) Dialysed purified 
fusion protein, Lane C.T) Control of temperature, contains of dialysed fusion and EK buffer, Lane 
16°C) Cleaved fusion protein incubated at 20°C, Lane 4°C) Cleaved fusion protein incubated at 
4°C, M) Protein marker 
 
 
       A              B 
Figure 6 A. The second purified protein profile on 18% SDS PAGE; Lane M) Protein marker, Lane 
1) Trx-hG-CSF fusion protein before EK cleavage, Lane 2) Trx-hG-CSF fusion protein after EK 
cleavage, Lane 3) Concentrated flow through fraction, Lane 4) Concentrated elution fraction with 
100 mM imidazole.Figure 6.B. Western Blot with anti-His primary antibodyLane M) Protein 
marker, Lane 1) Trx-hG-CSF fusion protein before EK cleavage,  Lane 2) Trx-hG-CSF after EK 
cleavage 
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Several fusion partners have been 
successfully investigated to enhance the 
solubility of hG-CSF with IPTG induced 
method, e.g. EDA or E.coli 2keto-3-deoxy-6-
phosphogluconate aldolase (Kang, 2014) and 
ArsC or arsenate reductase (Song, 2011). Das 
(2012) carried out an experiment with Trx·tag 
by IPTG induced method to increase the 
solubility of hGM-CSF, another colony 
stimulating factor which is useful to maintain 
post transplantation leukocytes level. In 
addition, Trx has the ability to be spesifically 
released from the E.coli cytoplasma by freeze-
thaw methods or osmotic shock in the presence 
of EDTA, which facilitates to isolate the 
protein from the cells (LaValielli, 1993).  
Two transformants of BL21(DE3)_ 
pET32a(+)_CSF3syn.Ec3 were randomly 
selected and gave the similar profile on 15% 
SDS PAGE (Figure 3). In our previous study, 
the expression level of soluble hG-CSF-Trx·tag 
was higher through autoinduction than IPTG-
induced method and it was increased by 
lowering the incubation temperature (Pratiwi, 
2012). Therefore, in this experiment, we detect 
the effectiveness of autoinduction method by 
comparing the amount of fusion protein from 
the soluble and insoluble fraction. The soluble 
fraction was extracted by centrifugating the 
lysed cells, while the insoluble fraction was 
prepared from residual cells pellet. To evaluate 
the amount of soluble and insoluble fusion 
protein, the thickness of target protein bands 
were semiquantitatively measured using ImageJ 
software and figured as area under curve (AUC) 
(Figure 3). The fusion protein was expressed 
approximately 49% in soluble fraction and  
51% in insoluble fraction. Consequently, the 
autoinduction condition still needs to be 
thoroughly optimized particularly for hG-CSF-
Trx·tag production. This method depends on 
the oxygenation state of the culture, the 
composition of the autoinduction medium, and 
time – temperature of incubation (Blommel, 
2007; Studier, 2005). Tyler (2005) found that 
0.6% or more of glycerol is important to get 
higher yield.   
 
Purification and characterization hG-CSF 
Some downstream steps were required 
to gain the hG-CSF e.g., the first purification 
step to remove E.coli endogenous proteins 
from fusion protein, and the cleavage of the 
fusion protein, followed by the second 
purification step to divide hG-CSF and 6×His-
Trx·tag. The purification was conducted 
through IMAC (Ni-NTA), a method which is 
widely used to purify the active and soluble 
recombinant protein based on the covalent 
binding of target protein-His·tag towards Ni2+ 
matrix (Bartlow, 2011, Awade, 1996). In order 
to recover the target protein, pH gradient or 
imidazole is typically used to release the protein 
target from the matrix (Porath, 1992). 
To mitigate endogenous protein 
contaminants, washing steps were performed in 
elevated imidazole concentrations prior to elute 
the fusion protein with an optimized imidazole 
concentration. The purified fusion protein was 
acquired from the first to the third elution 
fractions (Figure 4).  
The protein quantification was generated 
using ImageJ software by calculating the AUC 
of the protein from Figure 4. The crude protein 
contained of 10.46% fusion protein. The 
purification recovery was 83.56%, by comparing 
the total AUC of elution fractions towards the 
AUC of fusion protein from the crude protein, 
or 8.74% towards the overall crude protein.  
Each 6×His-Trx·tag and hG-CSF were 
separated by EK, a serine protease that 
recognizes the amino sequence -Asp-Asp-Asp-
Asp-Lys|X- with high specificity (Hopp, 1988). 
As a preliminary study, 1U of EK was added to 
100 µg fusion protein, then it was incubated at 
4°C and 20°C for 16 hours. The fusion protein 
was succesfully cleaved at both of those 
temperatures, but not completed yet (Figure 5), 
thus the ratio of fusion protein and 
enterokinase has to be optimized. 
 According to the amount of uncut 
protein,  the cleavage at 4°C was more effective 
than it was at 16°C. Besides, the degraded 
proteins which are less than 15 kDa were 
intensively found after incubation at 16°C. By 
using ImageJ software, the effciency of cleavage 
at 4°C was calculated. The AUC of each hG-
CSF, Trx, and uncut protein were compared to 
the AUC of purified fusion protein. The 
cleavage efficiency was obtained as 21.72% for 
hG-CSF and 39.31% for Trx. On the other 
hand, 38.05% protein was unsuccesfully 
cleaved.  
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The cleaved protein was subsequently 
purified using IMAC by trapping 6×His-
Trx·tag on the Ni2+ matrix. The hG-CSF was 
eluted in flow through fraction. At this step, 
flow through fraction and elution fraction were 
still recovered as mixture of 6×His-Trx·tag and 
hG-CSF (Figure 6.A). The larger scale 
experiment with enhanced binding process of 
protein – matrix is needed. In order to confirm 
whether the elution fraction possess 6×His-
Trx·tag, it was detected by western blot with 
anti-His primary antibody (Figure 6.B).  
 
CONCLUSION 
Human granulocyte colony stimulating 
factor has been successfully expressed in fusion 
with thioredoxin in E.coli BL21(DE3) through 
autoinduction method. A number of 49% of 
this protein was found as soluble fraction, 
whereas the other 51% was still found 
aggregated as IBs. It was succesfully purified 
using IMAC, cleaved from the fusion Trx 
partner and confirmed by western blot. 
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